ESMO CLINICAL LYMPHOMA, MYELOMA & LEUKEMIA

Hematology

Clinical Lymphoma, Myeloma & Leukemia (2027)

Editor in Chief: Sundar Jagannath, MD, Hagop Kantarjian, MD, Sagar Lonial, MD, Owen A. O’Connor, MD
Organizational Affiliations: International Myeloma Society and the Society of Hematologic Oncology, European Society for Medical Oncology

Clinical Lymphoma, Myeloma & Leukemia is the only journal of its clinical scope published in the United States. It includes articles on lymphoma, myeloma, and leukemias such as AML, ALL, CML, CLL, MDS and MPD. Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed bimonthly journal established in 2000. It features an international editorial board comprised of prominent thought leaders including Senior Editor-in-Chief Sundar Jagannath and Editors- in-Chief Dr. Owen O'Connor, Dr. Sagar Lonial and Dr. Hagop Kantarjian. Each issue is mailed free of charge to US-based medical oncologists and hematologists. Each issue of Clinical Lymphoma, Myeloma & Leukemia features original contributions, invited comprehensive reviews, and current trial reports, as well as meeting highlights and reports taken from major oncology meetings throughout the year. Also included are brief editorials of current news and the latest topics concerning lymphoma, myeloma and leukemia for clinicians.

Global Print Circulation
100
Avg. Global Monthly Visits
13,235
Avg. Global Monthly Unique Visitors
9,934
Avg. Global Monthly Page Views
23,962
Avg. Global eTOC Distribution
10,343
Circulation updated on 1st October 2026, based on 12-month monthly average October 2025-September 2026, eTOC Metrics: 12 Month Average of eTOC sends - October 2025 to September 2026, Monthly average web metrics based on the period of October 2025 to September 2026